Name | [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,piperazine |
---|---|
Synonyms |
hydrogène sulfate de (8R,9S,13S,14S)-13-méthyl-17-oxo-7,8,9,11,12,13,14,15,16,17-décahydro-6H-cyclopenta[a]phénanthrén-3-yle - pipérazine (1:1)
Estrone hydrogen sulfate compound with piperazine (1:1) Ogen ORTHO-EST Piperazinestron-sulfat Estropipate Estra-1,3,5(10)-trien-17-one 3-sulphate compound with Piperazine (1:1) (8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ylhydrogen-sulfat-piperazin(1:1) Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1) UNII-SVI38UY019 17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1) Estrone sulfate piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl hydrogen sulfate - piperazine (1:1) Sulestrex piperazine oestrone sulphate MFCD00867399 Harmogen EINECS 230-696-3 Piperazine estrone sulfate |
Description | Estropipate is a form of estrogen, used to treat symptoms of menopause, also used to prevent osteoporosis. |
---|---|
Related Catalog |
Molecular Formula | C22H32N2O5S |
---|---|
Molecular Weight | 436.565 |
Exact Mass | 436.203186 |
PSA | 113.11000 |
LogP | 4.21100 |
Storage condition | Store at RT |
CHEMICAL IDENTIFICATION
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H350 |
Precautionary Statements | P201-P280-P301 + P312 + P330-P308 + P313 |
Hazard Codes | T |
Risk Phrases | 45-22 |
Safety Phrases | 53-45 |
RIDADR | NONH for all modes of transport |
RTECS | KG7785000 |